[go: up one dir, main page]

SV2002000339A - Soluciones de acido acetilsalicilico ref. lea 33813-sv - Google Patents

Soluciones de acido acetilsalicilico ref. lea 33813-sv

Info

Publication number
SV2002000339A
SV2002000339A SV2001000339A SV2001000339A SV2002000339A SV 2002000339 A SV2002000339 A SV 2002000339A SV 2001000339 A SV2001000339 A SV 2001000339A SV 2001000339 A SV2001000339 A SV 2001000339A SV 2002000339 A SV2002000339 A SV 2002000339A
Authority
SV
El Salvador
Prior art keywords
ref
read
acid solutions
acetilsalicilic
acetilsalicilic acid
Prior art date
Application number
SV2001000339A
Other languages
English (en)
Inventor
Wolfgang Wiehl
Dietmar Bahn
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SV2002000339A publication Critical patent/SV2002000339A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SOLUCIONES DE AAS ADECUADAS PARA EL TRATAMIENTO TOPICO DEL DOLOR.
SV2001000339A 2000-03-07 2001-03-07 Soluciones de acido acetilsalicilico ref. lea 33813-sv SV2002000339A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10011032A DE10011032A1 (de) 2000-03-07 2000-03-07 Acetylsalicylsäure-Lösungen

Publications (1)

Publication Number Publication Date
SV2002000339A true SV2002000339A (es) 2002-06-07

Family

ID=7633806

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2001000339A SV2002000339A (es) 2000-03-07 2001-03-07 Soluciones de acido acetilsalicilico ref. lea 33813-sv

Country Status (9)

Country Link
EP (1) EP1263441A2 (es)
AR (1) AR028237A1 (es)
AU (1) AU2001272099A1 (es)
DE (1) DE10011032A1 (es)
GT (1) GT200100035A (es)
HN (1) HN2001000039A (es)
PE (1) PE20030207A1 (es)
SV (1) SV2002000339A (es)
WO (1) WO2001066115A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1716855A4 (en) * 2004-02-16 2008-06-18 Teikoku Seiyaku Kk REMEDY FOR EXTERNAL USE FOR SKIN AND MUCOUS DISEASES CAUSED BY VIRAL INFECTION
US8114910B2 (en) 2006-05-02 2012-02-14 Pfeinsmith S.A. (Pty) Ltd. Acidic composition
CA3064012A1 (en) * 2017-05-30 2018-12-06 Rhoshan Pharmaceuticals, Inc. In-vial deposition of a stable, sterile and crystalline o-acetyl salicylic acid (aspirin)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219548A (en) * 1978-09-01 1980-08-26 The Procter & Gamble Company Topical anti-inflammatory composition
IL68965A (en) * 1983-06-13 1987-02-27 Rafa Labor Ltd Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders
US5484606A (en) * 1994-01-24 1996-01-16 The Procter & Gamble Company Process for reducing the precipitation of difficulty soluble pharmaceutical actives
SK96196A3 (en) * 1994-01-24 1997-03-05 Procter & Gamble Process for solubilizing difficultly soluble pharmaceutical actives

Also Published As

Publication number Publication date
HN2001000039A (es) 2001-07-09
DE10011032A1 (de) 2001-09-13
EP1263441A2 (de) 2002-12-11
AR028237A1 (es) 2003-04-30
PE20030207A1 (es) 2003-04-16
GT200100035A (es) 2001-12-18
WO2001066115A3 (de) 2002-02-14
WO2001066115A2 (de) 2001-09-13
AU2001272099A1 (en) 2001-09-17

Similar Documents

Publication Publication Date Title
ES2092113T3 (es) Derivados fluoroalcoxibencilamino de heterociclos que contienen nitrogeno.
CY1119029T1 (el) Θεραπευτικη αντιμετωπιση συμπαγων εγκεφαλικων νεοπλασιων με ενα παραγωγο ραπαμυκινης
DK2052714T3 (da) Topisk gel-fremføringssystem til behandling af hudlidelser
UY26249A1 (es) Moléculas pequenas útiles en el tratamiento de las enfermedades inflamatorias ley 17164 art. 127
BR0211390A (pt) Tratamento de infecções da unha com no
UY26256A1 (es) Amidas de ácidos carboxílicos, medicamentos que contienen estos compuestos, su utilización y su preparación
IT1285770B1 (it) Composti corticoidei
ATE368023T1 (de) Hydroxydiphenyletherverbindungen
BR0114903A (pt) 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação
CY1105482T1 (el) Χρηση της αζιθρομυκινης στην τοπικη αγωγη οφθαλμικων μολυνσεων
ES2178761T3 (es) Utilizacion de 1-hidroxi-2-piridonas para el tratamiento de infe cciones cutaneas.
BR0209541A (pt) Uso das imidazotriazinonas 2-fenil-substituìdas
FI20000635A0 (fi) COMT-inhibiittoreiden käyttö analgeettina
DE60127131D1 (de) Tricyclische imidazopyridine
SV1996000008A (es) Uso de amidas de acido fenilciclohexilcarboxilicos
SV2002000339A (es) Soluciones de acido acetilsalicilico ref. lea 33813-sv
IT1306165B1 (it) Impiego di inibitori della sostanza p per il trattamento degliadenocarcinomi.
EA200200948A1 (ru) Лечение псориаза
ES2134184T3 (es) Empleo de etisterona para el tratamiento topico del acne o de la alopecia androgenetica.
ES2167721T3 (es) Utilizacion de 1-hidroxi-2-piridonas para el tratamiento de la dermatitis seborreica.
EA200200853A1 (ru) Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака
ATE368025T1 (de) Pleuromutilinderivate mit antimikrobieller wirkung
NO20005548D0 (no) Mykobakterieinhibitorer
IT1320192B1 (it) Composizione terapeutica per la cura della psoriasi.
GB0312566D0 (en) Veterinary composition for the topical treatment of traumatized or inflamed skin

Legal Events

Date Code Title Description
FD Lapse